Fairchem Organics Buyback 2026 vs Nectar Lifesciences Buyback 2025

Comparison between Fairchem Organics Buyback 2026 and Nectar Lifesciences Buyback 2025.

Buyback Details

Fairchem Organics Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Nectar Lifesciences Buyback 2025 is a Tender Offer proposed to list at BSE, NSE.

 Fairchem Organics Ltd.Nectar Lifesciences Ltd.
LogoFairchem Organics Buyback 2026 LogoNectar Lifesciences Buyback 2025 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹10 per share₹1 per share
Buyback Price₹800 per share₹27 per share
Issue Size4,25,000 shares3,00,00,000 shares
Issue Size (Amount)₹34.00 Crores₹81.00 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders29 : 48863,750
General Category55 : 6063,61,250

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,32,51,651
General Category for all other Eligible Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,67,48,349
RegistrarMUFG Intime India Pvt.Ltd.Kfin Technologies Ltd.
Lead ManagersMotilal Oswal Investment Advisors Ltd.Master Capital Services Ltd.
Necessity of the buyback
  • The Buyback will help the Company to distribute surplus cash to its shareholders holding equity shares thereby enhancing the overall return for them
  • The Buyback, which is being implemented through the Tender Offer route as prescribed under the Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares proposed to be brought back by the Company or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company's public shareholders, who would be classified as 'Small Shareholders';
  • The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by reduction in the equity base of the company, thereby leading to long-term increase in shareholder's value, and
  • The Buy Back gives an option to the shareholders holding Equity Shares of the Company, to either (i) choose to participate and get cash instead of Equity Shares to be accepted under the Buy Back Offer or (ii) choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buy Back Offer, without additional investment.
  • The buyback will help the company to return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
  • The buyback will help the company to optimize the capital structure;
  • The Buyback, which is being implemented through the Tender Offer route as prescribed under the SEBI Buyback Regulations, would involve allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved. The company believes that the reservation for small shareholders would benefit a large number of the Company's public shareholders, who get classified as "Small Shareholders, as per regulations 2(i)(n) of the SEBI Buyback Regulations.
  • The buyback may help in improving financial ratios like earnings per share, return on capital employed, and return on equity, by reduction in the equity base, thereby leading to long-term increase in shareholders' vlaue; and
  • The buyback gives an option to the shareholders holding Equity shares of the company, who can choose to participate and get cash in lieu of Equity shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the buyback offer, without additional investment.

Buyback Timetable

Fairchem Organics Buyback 2026 and Nectar Lifesciences Buyback 2025 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Fairchem Organics Buyback 2026 Buyback record date is Jan 05, 2026. Nectar Lifesciences Buyback 2025 Buyback record date is Dec 24, 2025.

 Fairchem Organics Ltd.Nectar Lifesciences Ltd.
Record DateJan 05, 2026Dec 24, 2025
Offer Open DateJan 08, 2026Dec 31, 2025
Offer Closure DateJan 14, 2026Jan 06, 2026
Last date for receipt of tender formsJan 14, 2026Jan 06, 2026
Finalisation of buybackJan 20, 2026Jan 12, 2026
Last Date for settlment of bidsJan 21, 2026Jan 13, 2026
Last Date for extinguishment of sharesFeb 02, 2026Jan 22, 2026

Financial Details and Other Relevent Information

Comparison of Fairchem Organics Buyback 2026 and Nectar Lifesciences Buyback 2025 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Fairchem Organics Ltd.Nectar Lifesciences Ltd.
Financial

Fairchem Organics Limited Financial Information (Restated Consolidated)

Fairchem Organics Limited's revenue decreased by 13% and profit after tax (PAT) dropped by 46% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Assets401.83334.31
Total Income539.24622.61
Profit After Tax21.9740.50
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Nectar Lifesciences Ltd.'s revenue decreased by 1% and profit after tax (PAT) dropped by 2376% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Total Income11.301,674.971,698.661,566.85
Profit After Tax-1.01-113.684.99-24.18
NET Worth716.87956.111,069.251,064.59
Reserves and Surplus694.44933.681,046.821,042.17
Total Borrowing458.85582.02635.54753.83
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Sep-2025 812.55 620.35 683.51
Oct-2025 818.90 740.00 763.61
Nov-2025 825.85 753.75 763.61

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.75 14.67
Oct-2025 16.01 13.31 14.26
Sep-2025 17.03 14.07 15.15
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Sep-2025 767.00 541.55 682.95
Oct-2025 827.90 745.00 764.20
Nov-2025 825.95 750.05 764.20

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.71 14.64
Oct-2025 15.76 13.10 14.18
Sep-2025 16.99 14.03 15.12

Compare with others

Compare:

Fairchem Organics Buyback 2026 and Nectar Lifesciences Buyback 2025